Search

Search Constraints

You searched for: Author/Creator Nakachi, Ichiro

Search Results

1. Antibody titers against SARS-CoV-2 decline, but do not disappear for several months. (February 2021)

2. Bevacizumab plus erlotinib versus erlotinib alone in Japanese patients with advanced, metastatic, EGFR-mutant non-small-cell lung cancer (NEJ026): overall survival analysis of an open-label, randomised, multicentre, phase 3 trial. Issue 1 (January 2022)

4. Clinical characteristics of 345 patients with coronavirus disease 2019 in Japan: A multicenter retrospective study. Issue 5 (November 2020)

5. Comprehensive and long-term surveys of COVID-19 sequelae in Japan, an ambidirectional multicentre cohort study: study protocol. Issue 1 (26th November 2021)

6. Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial. Issue 5 (May 2019)

7. Histologic transformation of epidermal growth factor receptor–mutated lung cancer. (May 2022)

8. Longitudinal Assessment of Prognostic Understanding in Patients with Advanced Lung Cancer and Its Association with Their Psychological Distress. (23rd September 2021)

9. Most Important Things and Associated Factors With Prioritizing Daily Life in Patients With Advanced Lung Cancer. Issue 12 (8th December 2022)

10. Multi-omics of NET formation and correlations with CNDP1, PSPB, and L-cystine levels in severe and mild COVID-19 infections. Issue 3 (March 2023)